In indolent lymphoproliferative malignancies, namely CLL and follicular lymphoma, deletions of CDKN2A are rare, and CDKN2A inactivation frequently correlates with the transformation to an aggressive lymphoma with adverse prognosis [28,29,30,31]. This evidence concerns the gene CDKN2A and follicular lymphoma.